Aphria
Seite 1 von 17 Neuester Beitrag: 25.04.21 01:06 | ||||
Eröffnet am: | 01.12.16 22:11 | von: mrmofitch10. | Anzahl Beiträge: | 408 |
Neuester Beitrag: | 25.04.21 01:06 | von: Simonejkraa | Leser gesamt: | 225.770 |
Forum: | Hot-Stocks | Leser heute: | 1 | |
Bewertet mit: | ||||
Seite: < | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... 17 > |
Jetzt mit Treasure Island Sativa und Grand Daddy Purps Indica im Online Shop!
Im Dezember gibts 30% Rabatt auf CannWay Produkte!
Final approval of the listing is subject to Aphria meeting certain standard and customary conditions required by the TSX, to be finalized on or before the TSX-imposed May 3, 2017, deadline. Aphria is confident that it will satisfy all requirements and.... " ENDE Zitat
Quelle:http://www.stockwatch.com/News/...2441710&symbol=APH®ion=C
Fazit: jeder hat noch den Kurssprung von CanopyGrowth vor Augen..... von damals 7 auf 17 :-)
Source:http://stockcharts.com/h-sc/ui?s=WEED.TO
Dazu habe ich in selbigem Wiki CGC aka WEED 9500 Stk mit knapp +12% verkauft...
nachfolgend habe ich versucht, die relevanten Information zu den bereits erfolgten und zukünftig geplanten Expansionen (Expansion Part I - Expansion Part IV); Zeitraum 2015 - 2018, darzustellen.
Part I - 3./2015 - additional 20´700 s.f. - total a.g.c. 2,500 kg - completed 10./2015
Part II - 6.-7./2016 - additional 57´000 s.f. - total a.g.c. 7.500 kg(ab 2017) completed 01./2016 > expected to be approved by HealthCanada by 4./2017
Part III - 6./2016 - total up to 300´000 s.f. - total a.g.c. 21.000 kg - expected completed 10/2017
Part IV - 1.72017 - additional 350´000 s.f. - tatal. a.g.c. 49.000kg - expected compl. in 06.72018
Zitat:" ...Part IV Expansion is now anticipated to include (1) 700,000 square feet of state-of-the-art greenhouses built up to the current standards of greenhouses operations in Leamington, for total greenhouse growing space of 1,000,000 square feet.. " ENDE Zitat
*s.f. = square feet
*a.g.c = total annual growing capacity
Zitat:"Aphria will grow and prepare the high yield cannabis for Medlab in Canada and Medlab will complete the manufacturing at a licensed Schedule 8 (S8) TGA approved facility, which Medlab expects will be in Australia....At this facility, the cannabis product will be combined with Medlab's patented medicine delivery system, NanoCelle™, which enables sub-micron sized particles to be taken by mouth spray, allowing a swifter and more direct absorption of medicine into the bloodstream...."The supply agreement with Medlab represents the first step in Aphria's International strategy. Choosing to take that step with an Australian public company, operating in the pharmaceutical space, with the resources to execute and a strategic vision consistent with Aphria's made Medlab a logical choice as Aphria's first international partner," Mr. Neufeld, Chief Executive Officer of Aphria, said.... " ENDE Zitat
Quelle/:
http://www.marketwired.com/press-release/...trial-asx-mdc-2152344.htm
https://aphria.com/assets/reports/PR_Aug_22.pdf
Zitat:""We are thrilled to partner with Aphria to help expand their patient base while opening a new revenue stream for our business," stated MassRoots CEO Isaac Dietrich. "As a technology platform, MassRoots is available in every state and country that regulates the production of cannabis and we could not be more excited to have a partner of Aphria's caliber in the Canadian market." "ENDE Zitat
"This partnership with MassRoots offers a fresh, innovative way to expand Aphria's patient base while helping to grow our digital presence," stated Aphria CEO Vic Neufeld. "MassRoots has the potential to be the leading technology platform in the cannabis sector and we look forward to leveraging their distribution channels and data to optimize our operations."
Quelle/n:
https://aphria.com/assets/reports/..._October_18_-_MassRoots__APH.pdf
http://www.otcmarkets.com/stock/MSRT/news/...panies?id=142657&b=y
https://www.wikifolio.com/de/de/wikifolio/...is-cannabinoids-industry
wikifolio-Indexzertifikat
ISIN: DE000LS9KTW8
Kurse per 23.02.2017 - 08:36
116,76 EUR Verkaufskurs (Bid) - 123,30 EUR Kaufkurs (Ask)
Investiertes Kapital
Erstemission 22.02.2017
Zertifikategebühr p.a. 0,95%
Performancegebühr 5%
Symbol WFOOCEBEEN
Erstellungsdatum 13.12.2016
Top-wikifolio-Rangliste Punkte 66
Indexstand 120,03
High Watermark 120,01
Performance seit Beginn +20,07%
Performance seit Jahresbeginn +33,30%
Performance 1 Monat +29,42%
52-Wochen-Hoch 123,98
Zitat:"... expect this uplisting to be great for Aphria's share price for two reasons....
Aphria Will Be A Component Of Most Canadian Index Funds
Up-listing to the TSX Index will make Aphria a component in most Canadian index funds.
This is important. Any time a billion-dollar fund manager or individual investors purchases a Canadian index fund, such as iShares MSCI Canada....they will be buying shares of Aphira.... " ENDE Zitat
Source:http://m.nasdaq.com/article/...ock-that-could-be-a-smash-hit-cm752226
wie nicht anders zu erwarten wird der Kurs nochmals, für alle die nicht zum Zug gekommen sind, gedrückt..... Up-Listing an die TSX erfolgt (angeblich) in der letzten Woche März , auf Anfang April
Zitat:"Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce it has closed its short form prospectus offering, on a bought deal basis, including the exercise in full of the underwriters' over-allotment option. A total of 11,500,000 common shares (the "Shares") of the Company were sold at a price of $5.00 per Share, for aggregate gross proceeds of $57,500,000 (the "Offering")."
Source:http://www.otcmarkets.com/stock/APHQF/news/...eal-Financing?id=151955
http://www.cantechletter.com/2017/03/...ce-target-raise-pi-financial/
Zitat:"Vic Neufeld, chief executive officer of Aphria, said:"Aphria has always held itself to the highest standards when it comes to the cultivation and production of medical cannabis. As part of this, we made a strategic investment i..... which enables us to produce medical cannabis that meets our exacting standards of quality, consistency and safety......
"Aphria is committed to product integrity through every step of the growing process. We make our own fertilizer, which significantly reduces the risk of unwanted chemicals that can be found in 'premixed' fertilizers. Additionally, we do not use chemical pesticides in the production of medical cannabis; we only use biological controls in the Leamington greenhouse. To be clear, Aphria has never supported the use of myclobutanil.........
"Since Aphria was founded, we have enforced a strict quality management program that continuously tests for pesticides,........
"Aphria management has over 35 years of experience in agriculture and 20 years in the pharmaceutical space, we don't need to rely on chemicals because we know how to grow naturally."
http://www.stockwatch.com/News/...2450644&symbol=APH®ion=C
Source:http://www.stockwatch.com/News/...2453618&symbol=APH®ion=C
"We're committed to continuing to build a robust portfolio of cannabis-infrastructure investments by backing innovate companies like MassRoots," stated Aphria CEO Vic Neufeld. "MassRoots has the potential to be the leading technology platform in the cannabis sector.... " ENDE Zitat
Source:http://www.stockwatch.com/News/...2456496&symbol=APH®ion=C
Stichpunkte sind:
- Expansion US-Markt
- Weiterer Invest in MassRoots (technischer Partner)
- 3-Mio-Invest in Arizona zur Produktion (Copperstate Farms)
- usw